Seastar Medical Holding Corp. (ICU)
1.98
+0.06
(+3.12%)
USD |
NASDAQ |
Nov 06, 10:20
Seastar Medical Enterprise Value : 1.354M for Nov. 5, 2026
Enterprise Value Chart
Historical Enterprise Value Data
| Date | Value |
|---|---|
| November 05, 2026 | 1.354M |
| November 04, 2026 | 1.865M |
| November 03, 2026 | 1.695M |
| November 02, 2026 | 2.504M |
| October 30, 2026 | 2.717M |
| October 29, 2026 | 3.015M |
| October 28, 2026 | 3.739M |
| October 27, 2026 | 3.910M |
| October 26, 2026 | 3.697M |
| October 23, 2026 | 3.441M |
| October 22, 2026 | 5.315M |
| October 21, 2026 | 6.679M |
| October 20, 2026 | 6.167M |
| October 19, 2026 | 6.423M |
| October 16, 2026 | 5.528M |
| October 15, 2026 | 6.21M |
| October 14, 2026 | 5.997M |
| October 13, 2026 | 8.468M |
| October 12, 2026 | 9.575M |
| October 09, 2026 | 8.553M |
| October 08, 2026 | 8.042M |
| October 07, 2026 | 9.022M |
| October 06, 2026 | 6.764M |
| October 05, 2026 | 8.297M |
| October 02, 2026 | 13.15M |
| Date | Value |
|---|---|
| October 01, 2026 | 9.149M |
| September 30, 2026 | 9.959M |
| September 29, 2026 | 8.340M |
| September 28, 2026 | 7.658M |
| September 25, 2026 | 7.744M |
| September 24, 2026 | 7.829M |
| September 23, 2026 | 8.212M |
| September 22, 2026 | 8.212M |
| September 21, 2026 | 8.425M |
| September 18, 2026 | 8.255M |
| September 17, 2026 | 8.072M |
| September 16, 2026 | 6.295M |
| September 15, 2026 | 6.040M |
| September 14, 2026 | 6.255M |
| September 11, 2026 | 6.082M |
| September 10, 2026 | 6.508M |
| September 09, 2026 | 6.380M |
| September 08, 2026 | 5.741M |
| September 04, 2026 | 5.869M |
| September 03, 2026 | 5.571M |
| September 02, 2026 | 5.443M |
| September 01, 2026 | 5.912M |
| August 31, 2026 | 6.508M |
| August 28, 2026 | 6.338M |
| August 27, 2026 | 6.380M |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Abbott Laboratories | 224.21B |
| AngioDynamics, Inc. | 477.80M |
| Alphatec Holdings, Inc. | 1.734B |
| AtriCure, Inc. | 3.030B |
| Baxter International, Inc. | 19.28B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -3.73M |
| Revenue (Quarterly) | 0.615M |
| Total Expenses (Quarterly) | 4.345M |
| EPS Diluted (Quarterly) | -0.9133 |
| Gross Profit Margin (Quarterly) | 91.22% |
| Profit Margin (Quarterly) | -606.5% |
| Earnings Yield | -198.4% |
| Normalized Earnings Yield | -198.44 |